Default company panoramic image

InfiniteVision Optics

IVO is a company that owns a unique concept of intraocular implants for treatment of cataract.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Strasbourg, Alsace, France
  • Currency EUR
  • Founded November 2010
  • Employees 0
  • Website

Company Summary

InfiniteVision Optics is a company that intends to commercialize a new concept of intraocular implant for cataract surgery intended for practitioners, public hospitals and private clinics. This unique concept was developed by Professor Ted Werblin, U.S. eye surgeon. The company is founded on the belief that each eye is unique and requires a customized solution.


  • Default avatar
    Hans OTT

    Dr. Hans H. Ott, PhD in Biochemistry, brings 25 years of experience in the ophthalmic industry. Formerly Vice-President Worldwide Professional Development and Scientific Promotion for Advanced Medical Optics (now Abbott Medical Optics) and CEO of the German and Swiss subsidiaries of the company.

  • Default avatar
    President - CMO

    Ted Werblin, Ophthalmic Surgeon, Associate Professor at the University of Virginia (USA) and inventor of the technology IVO, owned the rights to the intellectual property before divesting them to IVO. He is the author of numerous scientific publications in journals including the Journal of Cataract & Refractive Surgery (JCRS) and the Journal of Refractive Surgery (JRS). He performs about 1,000 surgical cases per year.

  • Default avatar
    Wilfrid GIRARD

    Wilfrid Girard, MBA, 14 years experience in the ophthalmic industry in the United States and Europe, formerly Director of the Europe business division Cataract Surgery Equipment / Retina at Advanced Medical Optics (now Abbott), previously Marketing Director, Europe Refractive Laser Surgery division, Bausch + Lomb.


  • Default avatar
    Corporate legal : LexCom (Paris IIe) ; PI : Loyer&Abello (Paris XVIIe)
    Default avatar
    Neos (Paris XVIe)

Previous Investors

  • Default avatar
    Remora Capital, Fonds de capital amorçage : 60K
    Default avatar
    Région Alsace, subvention FRFI (financement innovation) : 50K
    Default avatar
    OSEO PPA : 50K